(Q45227077)

English

Perspectives for the utilization of neutralizing human monoclonal antibodies as anti-HCV drugs.

scientific article published on 23 May 2008

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18554744

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18554744%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 January 2020

title

Perspectives for the utilization of neutralizing human monoclonal antibodies as anti-HCV drugs (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18554744

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18554744%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18554744

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18554744%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 January 2020

Nicasio Mancini

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18554744

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18554744%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1

Roberto Burioni

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18554744

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18554744%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 January 2020

author name string

Mario Perotti

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18554744

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18554744%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 January 2020

publication date

23 May 2008

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18554744

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18554744%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 January 2020

published in

Journal of Hepatology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18554744

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18554744%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 January 2020

volume

49

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18554744

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18554744%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 January 2020

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18554744

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18554744%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 January 2020

page(s)

299-300

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18554744

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18554744%20AND%20SRC:MED&resulttype=core&format=json

(Q45227077)

Perspectives for the utilization of neutralizing human monoclonal antibodies as anti-HCV drugs.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)